Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL23302259 | 0.96 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL9659849 | 0.84 | TSHR (0.31) | TSHRTDP1 | |
| SCHEMBL23872557 | 0.83 | — | — | |
| SCHEMBL9281487 | 0.81 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL9284822 | 0.81 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL24872796 | 0.78 | — | — | |
| SCHEMBL4697202 | 0.78 | — | — | |
| SCHEMBL9284847 | 0.75 | TDP1 (0.33) | TSHRTDP1 | |
| SCHEMBL9283307 | 0.75 | TDP1 (0.34) | TSHRTDP1 | |
| SCHEMBL24966662 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021499-B2 | Bis(6-methyl-3-sulphophenyl)(2-methylphenyl)phosphine, ammonium salt thereof, and method for producing same | KURARAY CO., LTD. (JP) | 2021-06-01 | — | — | US | claimed |
| US-10696701-B2 | Bis(6-methyl-3-sulphophenyl)phenylphosphine, ammonium salt thereof, and method for producing same | KURARAY CO., LTD. (JP) | 2020-06-30 | — | — | US | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-110590844-A | Preparation method for synthesizing tenofovir alafenamide by two-step method | 江西农业大学 | 2019-12-20 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| US-20190071460-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | HONDA ERIKO (JP) | 2019-03-07 | — | — | US | claimed |
| EP-2980093-B1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2019-01-09 | — | — | EP | claimed |
| US-20180141967-A1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2018-05-24 | — | — | US | claimed |
| EP-2980092-B1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2017-10-04 | — | — | EP | claimed |
| US-20160052948-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | claimed |
| US-20160052947-A1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | claimed |
| EP-2980093-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | claimed |
| EP-2980092-A1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | claimed |
| US-12016856-B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | ARDELYX, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. | 2023-08-10 | — | — | US | disclosed |
| EP-4056604-B1 | METHOD FOR PRODUCING COPOLYMER OF 1,3,7-OCTATRIENE AND STYRENE | KURARAY CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-0638537-B1 | Process for producing cyclobutanones | SUMITOMO CHEMICAL CO (JP) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996004289-A1 | HIGH ACTIVITY RUTHENIUM OR OSMIUM METAL CARBENE COMPLEXES FOR OLEFIN METATHESIS REACTIONS AND SYNTHESIS THEREOF | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1996-02-15 | — | — | WO | disclosed |
| US-5420356-A | Process for producing cyclobutanones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-05-30 | — | — | US | disclosed |
| EP-0638537-A1 | Process for producing cyclobutanones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | ASGR1, LAMP2, FCGR2A | TSHR 215/4885TDP1 3649/4885 |
| US-12016856-B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | SLC10A1, SLC10A2, FABP3 | TSHR 680/4885TDP1 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.